Search by Drug Name or NDC
NDC 67386-0130-91 Vyepti 100 mg/mL Details
Vyepti 100 mg/mL
Vyepti is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lundbeck Pharmaceuticals LLC. The primary component is EPTINEZUMAB.
MedlinePlus Drug Summary
Eptinezumab-jjmr injection is used to help prevent migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light). Eptinezumab-jjmr injection is in a class of medications called monoclonal antibodies. It works by blocking the action of a certain natural substance in the body that causes migraine headaches.
Related Packages: 67386-0130-91Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Eptinezumab-jjmr Injection
Product Information
| NDC | 67386-0130 |
|---|---|
| Product ID | 67386-130_d60f6c63-84c4-4b4e-a641-5cab738fc9aa |
| Associated GPIs | 67702015202020 |
| GCN Sequence Number | 080773 |
| GCN Sequence Number Description | eptinezumab-jjmr VIAL 100 MG/ML INTRAVEN |
| HIC3 | H3F |
| HIC3 Description | ANTIMIGRAINE PREPARATIONS |
| GCN | 47744 |
| HICL Sequence Number | 046372 |
| HICL Sequence Number Description | EPTINEZUMAB-JJMR |
| Brand/Generic | Brand |
| Proprietary Name | Vyepti |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | eptinezumab-jjmr |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/mL |
| Substance Name | EPTINEZUMAB |
| Labeler Name | Lundbeck Pharmaceuticals LLC |
| Pharmaceutical Class | Calcitonin Gene-related Peptide Antagonist [EPC], Calcitonin Gene-related Peptide Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA761119 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 67386-0130-91 (67386013091)
| NDC Package Code | 67386-130-91 |
|---|---|
| Billing NDC | 67386013091 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (67386-130-91) / 1 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2023-04-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |